Media coverage
9
Media coverage
Title XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa Media name/outlet Morningstar.com Country/Territory United States Date 23/10/19 URL https://www.morningstar.com/news/globe-newswire/7745568/xbiotech-announces-first-patient-enrolled-in-randomized-multi-center-clinical-study-evaluating-bermekimab-therapy-in-patients-with-hidradenitis-suppurativa Persons Alice Gottlieb Title XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa Media name/outlet TMC Net Country/Territory United States Date 23/10/19 URL www.tmcnet.com/usubmit/-xbiotech-announces-first-patient-enrolled-randomized-multi-center-/2019/10/23/9039981.htm Persons Alice Gottlieb Title XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa Media name/outlet StocksNewsFeed.com Country/Territory United States Date 23/10/19 URL https://stocksnewsfeed.com/globenewswire/xbiotech-announces-first-patient-enrolled-in-randomized-multi-center-clinical-study-evaluating-bermekimab-therapy-in-patients-with-hidradenitis-suppurativa/ Persons Alice Gottlieb Title XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa Media name/outlet Stockwatch Country/Territory Canada Date 23/10/19 URL www.stockwatch.com/News/Item.aspx?bid=U-z7745568-U%3aXBIT-20191023&symbol=XBIT®ion=U Persons Alice Gottlieb Title XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa Media name/outlet MarketScreener.com Country/Territory United States Date 23/10/19 URL https://www.marketscreener.com/XBIOTECH-INC-21506504/news/XBiotech-Announces-First-Patient-Enrolled-in-Randomized-Multi-Center-Clinical-Study-Evaluating-Berme-29440804/ Persons Alice Gottlieb Title XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa Media name/outlet Crwe World Country/Territory United States Date 23/10/19 URL crweworld.com/article/news-provided-by-globenewswire/1284910/xbiotech-announces-first-patient-enrolled-in-randomized-multi-center-clinical-study-evaluating-bermekimab-therapy-in-patients-with-hidradenitis-suppurativa Persons Alice Gottlieb Title XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa Media name/outlet Customer Zone 360.com Country/Territory United States Date 23/10/19 URL www.customerzone360.com/news/2019/10/23/9039981.htm Persons Alice Gottlieb Title XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa Media name/outlet GlobeNewswire Country/Territory United States Date 23/10/19 URL www.globenewswire.com/news-release/2019/10/23/1934071/0/en/XBiotech-Announces-First-Patient-Enrolled-in-Randomized-Multi-Center-Clinical-Study-Evaluating-Bermekimab-Therapy-in-Patients-with-Hidradenitis-Suppurativa.html Persons Alice Gottlieb Title XBiotech Inc: XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa (GlobeNewswire) Media name/outlet Avanza Bank AB Country/Territory Sweden Date 23/10/19 URL https://www.avanza.se/placera/pressmeddelanden/2019/10/23/xbiotech-inc-xbiotech-announces-first-patient-enrolled-in-randomized-multi-center-clinical-study-evaluating-bermekimab-therapy-in-patients-with-hidradenitis-suppurativa.html Persons Alice Gottlieb